Sacituzumab govitecan 180mg powder for solution for infusion vials

in short Sacituzumab govitecan 180mg inf vials

SNOMED code
40103611000001103
Active compound
Sacituzumab govitecan
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Sacituzumab govitecan — 180 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Trodelvy 180mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd)

in short Trodelvy 180mg pdr for concentrate for inf vials

Trodelvy 180mg powder for concentrate for solution for infusion vials

SNOMED code
40096511000001103
Supplier
Gilead Sciences Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Trodelvy 180mg powder for concentrate for solution for infusion vials (Gilead Sciences Ltd) 1 vial
40096611000001104   ref. pack
💯 Available

Legal category: POM
05391507146670
05391507146939

End:
NHS Indicative Price
£793
• Hospital
  • • Prescription Charges

Reference packs

Sacituzumab govitecan 180mg powder for solution for infusion vials 1 vial
SNOMED code
40096411000001102
Quantity and unit
1 vial
Packs